Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins

Chemistry and Physics of Lipids

Volumn 137, Issue 1-2, 2005, Pages 77-93

  Chang, Yusuo ^a,c   Wang, Zhengdong ^a   Schwan, Adrian L ^d   Wang, Zhongyi ^d   Holm, Bruce A ^e   Baatz, John E ^f   Notter, Robert H ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c University of Rochester   (United States)

^d UNIVERSITY OF GUELPH   (Canada)

^e UNIVERSITY AT BUFFALO   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

DEPN 8; Lipid analogs; Lung surfactants; Phosphonolipids; Surfactant therapy

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; ETHER; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; PHOSPHOLIPASE A2; PHOSPHOLIPID; SULFUR; SULFUR DIOXIDE;

ADSORPTION; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROPHOBICITY; LUNG ALVEOLUS SURFACE TENSION; LUNG INJURY; MOLECULAR DYNAMICS; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; SURFACE PROPERTY;

ADSORPTION; ANIMALS; CATTLE; ETHERS; HYDROPHOBICITY; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; SULFONES; SURFACE TENSION; THERMODYNAMICS;

BOVINAE;

EID: 26044432465     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2005.07.002     Document Type: Article

References (49)

1. B.N. Ames Assay of inorganic phosphate, total phosphate and phosphatases Meth. Enzymol. 8 1966 115 118
2. J.E. Baatz, Y. Zou, JT. Cox, Z. Wang, and RH. Notter High yield purification of lung surfactant proteins SP-B and SP-C and the effects on surface activity J. Prot. Expression Purif. 23 2001 180 190
3. Y. Chang, Z. Wang, R.H. Notter, Z. Wang, Q. Long, and A.L. Schwan Synthesis and interfacial behavior of sulfur-containing analogs of lung surfactant dipalmitoyl phosphatidylcholine Bioorg. Med. Chem. Lett. 14 2004 5983 5986
4. P. Chess, J.N. Finkelstein, B.A. Holm, and R.H. Notter Surfactant replacement therapy in lung injury R.H. Notter J.N. Finkelstein B.A. Holm Lung injury: Mechanisms, Pathophysiology, and Therapy 2005 Taylor and Francis Group Boca Raton 617 663
5. J.J. Cummings, B.A. Holm, M.L. Hudak, B.B. Hudak, W.H. Ferguson, and E.A. Egan A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs Am. Rev. Respir. Dis. 145 1992 999 1004
6. 2 degradation Can. J. Physiol. Pharmacol. 74 1996 957 963
7. E.A. Egan, RH. Notter, MS. Kwong, and DL. Shapiro Natural and artificial lung surfactant replacement therapy in premature lambs J. Appl. Physiol. 55 1983 875 883
8. G. Enhorning Pulsating bubble technique for evaluation of pulmonary surfactant J. Appl. Physiol. 43 1977 198 203
9. G. Enhorning, B. Shumel, L. Keicher, J. Sokolowski, and B.A. Holm Phospholipases introduced into the hypophase affect the surfactant film outlining a bubble J. Appl. Physiol. 73 1992 941 945
10. S.B. Hall, M.S. Bermel, Y.T. Ko, H.J. Palmer, G.A. Enhorning, and R.H. Notter Approximations in the measurement of surface tension with the oscillating bubble surfactometer J. Appl. Physiol. 75 1993 468 477
11. S.B. Hall, Z.R. Lu, A.R. Venkitaraman, R.W. Hyde, and R.H. Notter Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics J. Appl. Physiol. 72 1992 1708 1716
12. S.B. Hall, R.H. Notter, R.J. Smith, and R.W. Hyde Altered function of pulmonary surfactant in fatty acid lung injury J Appl. Physiol. 69 1990 1143 1149
13. S.B. Hall, A.R. Venkitaraman, J.A. Whitsett, B.A. Holm, and R.H. Notter Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants Am. Rev. Respir. Dis. 145 1992 24 30
14. S.B. Hall, Z. Wang, and R.H. Notter Separation of subfractions of the hydrophobic components of calf lung surfactant J. Lipid Res. 35 1994 1386 1394
15. B.A. Holm, L. Kelcher, M. Liu, J. Sokolowski, and G. Enhorning Inhibition of pulmonary surfactant function by phospholipases J. Appl. Physiol. 71 1991 317 321
16. B.A. Holm, Z. Wang, and R.H. Notter Multiple mechanisms of lung surfactant inhibition Pediatr. Res. 46 1999 85 93
17. M.L. Hudak, E.E. Farrell, A.A. Rosenberg, A.L. Jung, R.L. Auten, D.J. Durand, M.J. Horgan, S. Buckwald, M.R. Belcastro, P.K. Donohue, V. Carrion, W.M. Maniscalco, M.J. Balsan, B.A. Torres, R.R. Miller, R.D. Jansen, J.E. Graeber, K.M. Laskay, E.J. Matteson, E.A. Egan, A.S. Brody, D.J. Martin, M.M. Riddlesberger, P. Montogomery 21 Center Group A multicenter randomized masked comparison of natural vs synthetic surfactant for the treatment of respiratory distress syndrome J. Pediatr. 128 1996 396 406
18. M.L. Hudak, D.J. Martin, E.A. Egan, E.J. Matteson, J. Cummings, A.L. Jung, L.V. Kimberlin, R.L. Auten, A.A. Rosenberg, J.M. Asselin, M.R. Belcastro, P.K. Donahue, C.R. Hamm, R.D. Jansen, A.S. Brody, M.M. Riddlesberger, P. Montgomery 10 Center Group A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome Pediatrics 100 1997 39 50
19. R.A.W. Johnstone, and M.E. Rose A rapid, simple, and mild procedure for alkylation of phenols, alcohols, amides, and acids Tetrahedron 35 1979 2169 2173
20. W.H. Lin, S.G. Cramer, J.G. Turcotte, and R.S. Thrall A diether phosphonolipid surfactant analog, DEPN-8, is resistant to phospholipase-C cleavage Respiration 64 1997 96 101
21. H. Liu, R.Z. Lu, J.G. Turcotte, and R.H. Notter Dynamic interfacial properties of surface-excess films of phospholipids and phosphonolipid analogs. I. Effects of pH J. Colloid Interface Sci. 167 1994 378 390
22. H. Liu, J.G. Turcotte, and R.H. Notter Dynamic interfacial properties of surface-excess films of phospholipid and phosphonolipid analogs. II. Effects of chain linkage and headgroup structure J. Colloid Interface Sci. 167 1994 391 400
23. H. Liu, J.G. Turcotte, and R.H. Notter Thermotropic behavior of structurally-related phospholipids and phosphonolipid analogs of lung surfactant glycerophospholipids Langmuir 11 1995 101 107
24. K. Mizuno, M. Ikegami, C.-M. Chen, T. Ueda, and A.H. Jobe Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant Pediatr. Res. 37 1995 271 276
25. S. Morris-Natschke, J.R. Surles, L.W. Daniel, M.E. Berens, E.J. Modest, and C. Piantadosi Synthesis of sulfur analogs of alkyl lysophospholipid and neoplastic cell growth inhibitory properties J. Med. Chem. 29 1986 2114 2117
26. M. Nali, B. Rindone, E. Bosone, P. Farina, S. Innocenti, and U. Valcavi New potential immunoenhancing compounds. II. Synthesis of 1-deoxy-1- thiophosphatidylcholine derivatives Gazz. Chim. Ital. 116 1986 25 27
27. D. Niewoehner, K. Rice, A. Sinha, and D. Wangensteen Injurious effects of lysophosphatidylcholine on barrier properties of alveolar epithelium J. Appl. Physiol. 63 1987 1979 1986
28. R. Notter, R. Taubold, and J. Finkelstein Comparative adsorption of natural lung surfactant, extracted phospholipids, and synthetic phospholipid mixtures Chem. Phys. Lipids 33 1983 67 80
29. R.H. Notter Lung Surfactants: Basic Science and Clinical Applications 2000 Marcel Dekker, Inc. New York 444 pp
30. R.H. Notter, S. Smith, R.D. Taubold, and J.N. Finkelstein Path dependence of adsorption behavior of mixtures containing dipalmitoyl phosphatidylcholine Pediatr. Res. 16 1982 515 519
31. 2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study Acta Paediatr. 90 2001 412 416
32. W. Seeger, C. Grube, A. Günther, and R. Schmidt Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations Eur. Respir. J. 6 1993 971 977
33. Y. Shin Spectrophotometric ultramicrodetermination of inorganic phosphorus and lipid phosphorus in serum Anal. Chem. 34 1962 1164 1166
34. V. Skita, D.W. Chester, C.J. Oliver, J.G. Turcotte, and R.H. Notter Bilayer characteristics of a diether phosphonolipid analog of the major lung surfactant glycerophospholipid dipalmitoyl phosphatidylcholine J. Lipid Res. 36 1995 1116 1127
35. L.C. Stewart, and M. Kates Synthesis and characterization of deuterium-labeled dihexadecylglycerol and diphytanylglycerol phospholipids Chem. Phys. Lipids 50 1989 23 42
36. S.A. Tabak, and RH. Notter A modified technique for dynamic surface pressure and relaxation measurements at the air-water interface Rev. Sci. Instrum. 48 1977 1196 1201
37. J.C. Touchstone, J.C. Chen, and K.M. Beaver Improved separation of phospholipids in thin-layer chromatography Lipids 15 1980 61 62
38. 2 in ARDS pathogenesis Mol. Med. Today 5 1999 244 249
39. J.G. Turcotte, W.H. Lin, P.E. Pivarnik, A.M. Sacco, M.S. Bermel, Z. Lu, and R.H. Notter Chemical synthesis and surface activity of lung surfactant phospholipid analogs. II. Racemic N-substituted diether phosphonolipids Biochim. Biophys. Acta 1084 1991 1 12
40. J.G. Turcotte, A.M. Sacco, J.M. Steim, S.A. Tabak, and R.H. Notter Chemical synthesis and surface properties of an analog of the pulmonary surfactant dipalmitoyl phosphatidylcholine analog Biochim. Biophys. Acta 488 1977 235 248
41. 2 in the pathobiology of disease Lab. Invest. 55 1986 391 404
42. Vermont-Oxford Neonatal Network A multicenter randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome Pediatrics 97 1996 1 6
43. Z. Wang, J.E. Baatz, B.A. Holm, and R.H. Notter Content-dependent activity of lung surfactant protein B (SP-B) in mixtures with lipids Am. J. Physiol. 283 2002 L897 L906
44. Z. Wang, O. Gurel, J.E. Baatz, and R.H. Notter Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in surface-active interactions with phospholipids J. Lipid Res. 37 1996 1749 1760
45. Z. Wang, S.B. Hall, and R.H. Notter Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids J. Lipid Res. 36 1995 1283 1293
46. Z. Wang, B.A. Holm, S. Matalon, and R.H. Notter Surfactant activity and dysfunction in lung injury R.H. Notter J.N. Finkelstein B.A. Holm Lung Injury: Mechanisms, Pathophysiology, and Therapy 2005 Taylor and Francis Group Boca Raton 297 352
47. Z. Wang, and R.H. Notter Additivity of protein and non-protein inhibitors of lung surfactant activity Am. J. Respir. Crit. Care Med. 158 1998 28 35
48. Z. Wang, A.L. Schwan, L.L. Lairson, J.S. O'Donnell, G.F. Byrne, A. Foye, B.A. Holm, and R.H. Notter Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine Am. J. Physiol. 285 2003 L550 L559
49. D.F. Willson, N.J. Thomas, B.P. Markovitz, L.A. Bauman, J.V. DiCarlo, S. Pon, B.R. Jacobs, L.S. Jefferson, M.R. Conaway, E.A. Egan Pediatric Acute Lung Injury and Sepsis Investigators Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial JAMA 293 2005 470 476